NASHUA, N.H., Aug. 3, 2011 /PRNewswire/ -- Resonetics introduces the RapidX250 laser micromachining system, developed for Universities and Corporate research to fabricate microfluidics, MEMs and medical devices in a rapid prototype fashion with tolerances approaching 1 micron. Traditionally MEMs devices are fabricated by traditional semiconductor lithography but the multi-step process takes significant time. The RapidX250 uses a multi-wavelength excimer laser (193nm and 248nm) to directly fabricate the structures in a single step, drastically reducing prototype time.
Compared with other lasers and methods, the RapidX250 is very flexible, able to micro fabricate 2-D (flat sheets, tubes) and 3-D parts (balloons, non-planar surfaces) , including XYZ, theta and goniometer. At 193nm laser wavelength, the laser can ablate cleanly fluropolymers (such as nylon, pebax, Teflon), bioabsorbable polymers and glass. The system has a quick exchange scheme to allow the user to switch to 248nm laser wavelength, ideal for machining polymers, ceramic and metals (such as stents)
And lastly the RapidX250 was designed to be user friendly with a DXF file-to-CNC converter to quickly convert concepts into prototypes, ideal for a multi-user environment
About Resonetics LLC:
Resonetics is the largest total solution provider of laser micromachining products and services in the world. It is also regarded as having the largest independent plastic (polymer) laser micromachining facility with more than 50 UV-based laser micromachining systems and with three clean rooms.
Laser micromachining represents a critical fabrication technology for the manufacturing of medical devices, diagnostics, and a variety of non-medical products as the machining features become increasingly small.
The US-based company has three separate business divisions: The Medical Division, The Laser Micromachining Division (for Contract Manufacturing Services) and The Laser Systems Division (for capital equipment).
For further information, please contact:
|SOURCE Resonetics LLC|
Copyright©2010 PR Newswire.
All rights reserved